Preeclampsia, a dangerous pregnancy condition marked by high blood pressure and protein in urine, affects about one in 12 pregnancies in the U.S. Currently, the only cure is delivering the baby, which can lead to premature birth. However, new research suggests blood filtering might offer an alternative treatment. In a pilot study with 16 women experiencing preterm preeclampsia, researchers safely reduced blood pressure by filtering out a protein called sFlt-1. This approach, which avoids potential harm to the fetus, could pave the way for a targeted treatment. The study, published in Nature Medicine, highlights the potential of blood filtering, a technique already used in other medical and wellness contexts, to address preeclampsia. Further research is needed to confirm these findings and develop a viable treatment option.
QUESTION: How might the development of a targeted treatment for preeclampsia change the experience of pregnancy for future generations?
Blood filtering could help treat preeclampsia, pilot study suggests
